# Valhi Inc: overview

VHI · NYSE · CIK 59255 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/vhi.md) · [Financials](/companies/vhi/financials.md) · [Filings](/companies/vhi/filings.md) · [Insiders](/companies/vhi/insiders.md)

Latest reported revenue: [$606.1m](/filings/0001104659-26-092027.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001104659-26-092027).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [534](/filings/0001104659-25-107777.md) | [481 d](/filings/0001104659-26-025847.md) | [539](/filings/0001104659-26-057165.md) | [540](/filings/0001104659-26-092027.md) | [504](/filings/0001104659-25-107777.md) | [495 d](/filings/0001104659-26-025847.md) | [560](/filings/0001104659-26-057165.md) | [606](/filings/0001104659-26-092027.md) |
| Gross margin | % | [21.8%](/filings/0001104659-25-107777.md) | [20.9% d](/filings/0001104659-26-025847.md) | [22.7%](/filings/0001104659-26-057165.md) | [14.5%](/filings/0001104659-26-092027.md) | [12.0%](/filings/0001104659-25-107777.md) | [6.9% d](/filings/0001104659-26-025847.md) | [18.4%](/filings/0001104659-26-057165.md) | [19.8%](/filings/0001104659-26-092027.md) |
| Operating margin | % | [12.7%](/filings/0001104659-25-107777.md) | [11.8% d](/filings/0001104659-26-025847.md) | [9.3%](/filings/0001104659-26-057165.md) | [6.6%](/filings/0001104659-26-092027.md) | [1.7%](/filings/0001104659-25-107777.md) | [(6.2%) d](/filings/0001104659-26-025847.md) | [5.9%](/filings/0001104659-26-057165.md) | [11.2%](/filings/0001104659-26-092027.md) |
| Net margin | % | [10.8%](/filings/0001104659-25-107777.md) | [4.7% d](/filings/0001104659-26-025847.md) | [3.1%](/filings/0001104659-26-057165.md) | [0.2%](/filings/0001104659-26-092027.md) | [(4.4%)](/filings/0001104659-25-107777.md) | [(10.8%) d](/filings/0001104659-26-025847.md) | [0.4%](/filings/0001104659-26-057165.md) | [3.7%](/filings/0001104659-26-092027.md) |
| Diluted EPS | $ per share | [2.01](/filings/0001104659-25-107777.md) | not reported | [0.59](/filings/0001104659-26-057165.md) | [0.03](/filings/0001104659-26-092027.md) | [(0.78)](/filings/0001104659-25-107777.md) | not reported | [0.07](/filings/0001104659-26-057165.md) | [0.78](/filings/0001104659-26-092027.md) |
| Free cash flow | $m | [3.9 d](/filings/0001104659-25-107777.md) | [33.3 d](/filings/0001104659-26-025847.md) | [(169)](/filings/0001104659-26-057165.md) | [9.1 d](/filings/0001104659-26-092027.md) | [(12.3) d](/filings/0001104659-25-107777.md) | [89.8 d](/filings/0001104659-26-025847.md) | [(56.7)](/filings/0001104659-26-057165.md) | [41.9 d](/filings/0001104659-26-092027.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,296](/filings/0001558370-24-002728.md) | [2,223](/filings/0001558370-25-002409.md) | [1,922](/filings/0001104659-26-025847.md) | [2,105](/filings/0001104659-26-025847.md) | [2,077](/filings/0001104659-26-025847.md) |
| Gross margin | % | [25.3%](/filings/0001558370-24-002728.md) | [22.1%](/filings/0001558370-25-002409.md) | [12.8%](/filings/0001104659-26-025847.md) | [20.2%](/filings/0001104659-26-025847.md) | [14.2%](/filings/0001104659-26-025847.md) |
| Operating margin | % | [13.9%](/filings/0001558370-24-002728.md) | [10.8%](/filings/0001558370-25-002409.md) | [1.8%](/filings/0001104659-26-025847.md) | [10.0%](/filings/0001104659-26-025847.md) | [3.0%](/filings/0001104659-26-025847.md) |
| Net margin | % | [5.5%](/filings/0001558370-24-002728.md) | [3.9%](/filings/0001558370-25-002409.md) | [(0.5%)](/filings/0001104659-26-025847.md) | [5.1%](/filings/0001104659-26-025847.md) | [(2.8%)](/filings/0001104659-26-025847.md) |
| Diluted EPS | $ per share | [4.46](/filings/0001558370-24-002728.md) | [3.06](/filings/0001558370-25-002409.md) | [(0.35)](/filings/0001104659-26-025847.md) | [3.79](/filings/0001104659-26-025847.md) | [(2.02)](/filings/0001104659-26-025847.md) |
| Free cash flow | $m | [396](/filings/0001558370-24-002728.md) | [(32.7)](/filings/0001558370-25-002409.md) | [(44.6)](/filings/0001104659-26-025847.md) | [13.1](/filings/0001104659-26-025847.md) | [(82.1)](/filings/0001104659-26-025847.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/vhi/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BRIDGEWAY CAPITAL MANAGEMENT, LLC](/funds/1107261.md) | 2026-06-30 | $3.2m | 219,967 |  | Reduced −9,500 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $2.8m | 189,224 |  | Added +21,868 |
| [Empowered Funds, LLC](/funds/1592828.md) | 2026-06-30 | $2.1m | 140,076 |  | Reduced −3,000 |
| [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $1.9m | 129,117 |  | Added +700 |
| [National Philanthropic Trust](/funds/1785342.md) | 2026-06-30 | $1.3m | 87,717 |  | Unchanged |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $942.5k | 64,248 |  | Reduced −6,259 |
| [Bank of New York Mellon Corp](/funds/1390777.md) | 2026-06-30 | $686.8k | 46,819 |  | Reduced −196 |
| [NORTHERN TRUST CORP](/funds/73124.md) | 2026-06-30 | $590.1k | 40,227 |  | Reduced −40 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $561.6k | 38,283 |  | Added +454 |
| [JACOBS LEVY EQUITY MANAGEMENT, INC](/funds/884414.md) | 2026-06-30 | $461.0k | 31,426 |  | Reduced −3,043 |

## Recent filings

[All 1,004 filings](/companies/vhi/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-06 | 16:18 ET | [8-K](/filings/0000059255-26-000033.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000059255-26-000033 |
| 2026-08-06 | 16:17 ET | [10-Q](/filings/0001104659-26-092027.md) | Quarterly report, period 2026-06-30 | 0001104659-26-092027 |
| 2026-06-22 | 16:17 ET | [8-K](/filings/0000059255-26-000030.md) | 5.02 Departure or appointment of officers or directors | 0000059255-26-000030 |
| 2026-05-21 | 16:16 ET | [8-K](/filings/0000059255-26-000027.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000059255-26-000027 |
| 2026-05-07 | 16:21 ET | [8-K](/filings/0000059255-26-000020.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000059255-26-000020 |
| 2026-05-07 | 16:18 ET | [10-Q](/filings/0001104659-26-057165.md) | Quarterly report, period 2026-03-31 | 0001104659-26-057165 |
| 2026-04-01 | 16:17 ET | [DEF 14A](/filings/0000059255-26-000012.md) | Proxy statement, period 2026-05-21 | 0000059255-26-000012 |
| 2026-03-10 | 16:16 ET | [8-K](/filings/0000059255-26-000007.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000059255-26-000007 |
| 2026-03-10 | 16:16 ET | [10-K](/filings/0001104659-26-025847.md) | Annual report, period 2025-12-31 | 0001104659-26-025847 |
| 2026-03-05 | 16:16 ET | [8-K](/filings/0000059255-26-000003.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000059255-26-000003 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001104659-26-025847.md), filed Mar 10, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/ffe80b5f-c517-4f6f-be70-4ff6fcfb8a0e)

## About the filer

- CIK: 59255
- Tickers: VHI
- Exchange: NYSE
- SIC code: 2810 Industrial Inorganic Chemicals
- State of incorporation: DE
- Filer category: Non-accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:19 ET. No prices; not investment advice.